Evidence map›Paper›PMID 26164716›Full record

ArticleThe international journal of neuropsychopharmacology2015

Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits.

Paula L Vieira-Brock, Lisa M McFadden, Shannon M Nielsen, Misty D Smith, Glen R Hanson, Annette E Fleckenstein

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Nicotine Activating αMolecular neurobiology · 2022
    Article
  7. Neurotoxicity of e-cigarettes.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2020
    Review
  8. Article
  9. Article
  10. Review
  11. Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions.Clinical pharmacology and translational medicine · 2017
    Article
  12. Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits.The Journal of pharmacology and experimental therapeutics · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Paula L Vieira-BrockDepartment of Pharmacology and Toxicology (Dr Vieira-Brock, Dr McFadden, Ms Nielsen, Dr Smith, Dr Hanson, and Dr Fleckenstein), and School of Dentistry (Drs Smith, Hanson, and Fleckenstein), University of Utah, Salt Lake City, UT.
Lisa M McFaddenDepartment of Pharmacology and Toxicology (Dr Vieira-Brock, Dr McFadden, Ms Nielsen, Dr Smith, Dr Hanson, and Dr Fleckenstein), and School of Dentistry (Drs Smith, Hanson, and Fleckenstein), University of Utah, Salt Lake City, UT.
Shannon M NielsenDepartment of Pharmacology and Toxicology (Dr Vieira-Brock, Dr McFadden, Ms Nielsen, Dr Smith, Dr Hanson, and Dr Fleckenstein), and School of Dentistry (Drs Smith, Hanson, and Fleckenstein), University of Utah, Salt Lake City, UT.
Misty D SmithDepartment of Pharmacology and Toxicology (Dr Vieira-Brock, Dr McFadden, Ms Nielsen, Dr Smith, Dr Hanson, and Dr Fleckenstein), and School of Dentistry (Drs Smith, Hanson, and Fleckenstein), University of Utah, Salt Lake City, UT.
Glen R HansonDepartment of Pharmacology and Toxicology (Dr Vieira-Brock, Dr McFadden, Ms Nielsen, Dr Smith, Dr Hanson, and Dr Fleckenstein), and School of Dentistry (Drs Smith, Hanson, and Fleckenstein), University of Utah, Salt Lake City, UT.
Annette E FleckensteinDepartment of Pharmacology and Toxicology (Dr Vieira-Brock, Dr McFadden, Ms Nielsen, Dr Smith, Dr Hanson, and Dr Fleckenstein), and School of Dentistry (Drs Smith, Hanson, and Fleckenstein), University of Utah, Salt Lake City, UT. annette.fleckenstein@hsc.utah.edu.
Smithsonian Institution · US

Funding

Venoms, Biological Resources, Molecular BiologyP01GM048677 · NIGMS · UNIVERSITY OF UTAH · PI OLIVERA, BALDOMERO M · 1993 to 2018
$32.2M
Vmat AND NEUROTOXICITYP01DA013367 · NIDA · UNIVERSITY OF UTAH · PI ALBURGES, MARIO · 2001 to 2012
$10.1M
Psychostimulants and Monoamine TransportersR01DA011389 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 2003 to 2012
$2.5M
Novel nAChR-Targeted PeptidesR01GM103801 · NIGMS · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2012 to 2019
$2.4M
Role of Neurotensin Systems in Methamphetamine Self AdministrationR01DA031883 · NIDA · UNIVERSITY OF UTAH · PI HANSON, GLEN R · 2012 to 2016
$1.5M
K02 ApplicationK02DA019447 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 2005 to 2014
$1.3M
Serotonergic changes in the frontal cortex during methamphetamine reinstatementR00DA036012 · NIDA · UNIVERSITY OF SOUTH DAKOTA · PI MCFADDEN, LISA M · 2016 to 2018
$747k
METHAMPHETAMINE AND DOPAMINE TRANSPORTERSR29DA011389 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 1998 to 2002
$329k
Serotonergic changes in the frontal cortex during methamphetamine reinstatementK99DA036012 · NIDA · UNIVERSITY OF UTAH · PI MCFADDEN, LISA M · 2014 to 2015
$251k
Howard Hughes Medical Institute 560067777NIDA NIH HHS DA019447NIDA NIH HHS DA031883NIDA NIH HHS DA036012NIDA NIH HHS DA11389NIDA NIH HHS DA13367NIDA NIH HHS K02 DA019447NIDA NIH HHS K99 DA036012NIDA NIH HHS P01 DA013367NIDA NIH HHS R00 DA036012NIDA NIH HHS R01 DA011389NIDA NIH HHS R01 DA031883NIDA NIH HHS R29 DA011389NIGMS NIH HHS GM103801NIGMS NIH HHS GM48677NIGMS NIH HHS P01 GM048677NIGMS NIH HHS R01 GM103801
6 · The paper itself

Abstract

backgroundPrevious studies have demonstrated that methamphetamine abuse leads to memory deficits and these are associated with relapse. Furthermore, extensive evidence indicates that nicotine prevents and/or improves memory deficits in different models of cognitive dysfunction and these nicotinic effects might be mediated by hippocampal or cortical nicotinic acetylcholine receptors. The present study investigated whether nicotine attenuates methamphetamine-induced novel object recognition deficits in rats and explored potential underlying mechanisms.

methodsAdolescent or adult male Sprague-Dawley rats received either nicotine water (10-75 μg/mL) or tap water for several weeks. Methamphetamine (4 × 7.5mg/kg/injection) or saline was administered either before or after chronic nicotine exposure. Novel object recognition was evaluated 6 days after methamphetamine or saline. Serotonin transporter function and density and α4β2 nicotinic acetylcholine receptor density were assessed on the following day.

resultsChronic nicotine intake via drinking water beginning during either adolescence or adulthood attenuated the novel object recognition deficits caused by a high-dose methamphetamine administration. Similarly, nicotine attenuated methamphetamine-induced deficits in novel object recognition when administered after methamphetamine treatment. However, nicotine did not attenuate the serotonergic deficits caused by methamphetamine in adults. Conversely, nicotine attenuated methamphetamine-induced deficits in α4β2 nicotinic acetylcholine receptor density in the hippocampal CA1 region. Furthermore, nicotine increased α4β2 nicotinic acetylcholine receptor density in the hippocampal CA3, dentate gyrus and perirhinal cortex in both saline- and methamphetamine-treated rats.

conclusionsOverall, these findings suggest that nicotine-induced increases in α4β2 nicotinic acetylcholine receptors in the hippocampus and perirhinal cortex might be one mechanism by which novel object recognition deficits are attenuated by nicotine in methamphetamine-treated rats.

Indexed as

Administration, OralAgingAnimalsCA1 Region, HippocampalDentate GyrusDrinking WaterExploratory BehaviorMaleMemory DisordersMethamphetamineNicotineNicotinic AgonistsNootropic AgentsRats, Sprague-DawleyReceptors, NicotinicRecognition, PsychologyDrinking WaterMethamphetamineNicotineNicotinic Agonistsnicotinic receptor alpha4beta2Nootropic AgentsReceptors, NicotinicSerotonin Plasma Membrane Transport ProteinsSlc6a4 protein, ratMethamphetaminenicotinenicotinic receptorsnovel object recognition memoryserotonin transporter

Identifiers

PMID26164716
PMCPMC4675982
OpenAlexW2272911573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.